אלקסן
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CYTARABINE
Available from:
NOVARTIS ISRAEL LTD
ATC code:
L01BC01
Pharmaceutical form:
תמיסה להזרקה\אינפוזיה
Composition:
CYTARABINE 50 MG / 1 ML
Administration route:
תוך-שדרתי, תת-עורי, תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
EBEWE PHARMA GES.M.B.H NFG. KG, AUSTRIA
Therapeutic group:
CYTARABINE
Therapeutic area:
CYTARABINE
Therapeutic indications:
For induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas ( non-Hodgkin's lymphomas of high malignancy).
Authorization date:
2020-11-30
